Article · 21 Jul 2025
Conference abstractPublished 16 Sep 2020
Antioxidant and Antidiabetic activity of chalcone cb6 (E)-3-(4-Flourophenyl)-1-Phenylprop-2-en-1-one
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
. Diabetes is a metabolic disorder having serious consequence on health. The pharmacological treatment of diabetes mellitus may involve the use of medications as well as proper diet. Chalcones are flavonoid precursors and have shown a number of antioxidant properties. The current study was conducted to evaluate the antidiabetic and antioxidant activity of newly synthesized chalcone derivative cb6 (E)-3-(4-flourophenyl)-1-phenylprop-2-en-1-one. Hyperglycemia was induced by using alloxan monohydrate intraperitoneally (150mg/kg). In this study 50 albino wister rats were divided into 5 groups. First group was on normal routine diet; second group was given alloxan monohydrated; group 3 was given Glibenclamide; group 4 ( treated 1) was treated by using research compound at dose rate of 5ml/kg; group 5 ( treated 2) was given research compound at dose rate of 10ml/kg. Antidiabetic activity of chemical compound was determined by performing biochemical and histopathological analysis. Antidiabetic activity of chemical compound in comparison to the activity of synthetic drug glibenclamide was determined. The statistical analysis of variance (ANOA) was performed and the significance among different groups was determined by DMR (Dunca Multiple Range) test. Results of study indicated that chalcone cb6 significantly reversed the alloxaninduced hyperglycemia by improving biochemical and oxidative stress parameters. Histo h analysis also showed the antioxidant and antihyperglycemic potential of chalcone cb6. cb6 improved the activity of endocrine tissues of pancreas by decreasing the oxidative stress by its free radical scavenging activity.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Research Journal of Pharmacy and Pharmacology.
Article · 28 Mar 2025
Clinical Trials in Pharmacology: Bridging Research and Therapeutic Application
Article · 28 Mar 2025
Drug Formulation and Delivery Systems: Engineering Precision in Therapeutics
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Research Journal of Pharmacy and Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hafsa Iqbal”
